Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Results by Age, Disease Duration, and Baseline "Off" Time

S Isaacson; Lorenzo G Di; M Facheris; V Fung; T Henriksen; K Ikenaka; J Jia; D Kern; P Kukreja; Garcia D Santos; A Spiegel; Z Zhang; L Bergmann; C Carroll

doi:10.1111/ene.15466

Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Results by Age, Disease Duration, and Baseline "Off" Time

S Isaacson
, Lorenzo G Di
, M Facheris
, V Fung
, T Henriksen
, K Ikenaka
, J Jia
, D Kern
, P Kukreja
, Garcia D Santos
, A Spiegel
, Z Zhang
, L Bergmann
, C Carroll

Peninsula Medical School

Research output: Contribution to conference › Conference paper (not formally published) › peer-review

Original language	English
DOIs	https://doi.org/10.1111/ene.15466
Publication status	Published - Jul 2022

Access to Document

10.1111/ene.15466

Cite this

@conference{f7a81d39eb614412ac4bbb3add66aa03,

title = "Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Results by Age, Disease Duration, and Baseline {"}Off{"} Time",

author = "S Isaacson and Di, \{Lorenzo G\} and M Facheris and V Fung and T Henriksen and K Ikenaka and J Jia and D Kern and P Kukreja and Santos, \{Garcia D\} and A Spiegel and Z Zhang and L Bergmann and C Carroll",

year = "2022",

month = jul,

doi = "10.1111/ene.15466",

language = "English",

}

TY - CONF

T1 - Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Results by Age, Disease Duration, and Baseline "Off" Time

AU - Isaacson, S

AU - Di, Lorenzo G

AU - Facheris, M

AU - Fung, V

AU - Henriksen, T

AU - Ikenaka, K

AU - Jia, J

AU - Kern, D

AU - Kukreja, P

AU - Santos, Garcia D

AU - Spiegel, A

AU - Zhang, Z

AU - Bergmann, L

AU - Carroll, C

PY - 2022/7

Y1 - 2022/7

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000815254002106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008

U2 - 10.1111/ene.15466

DO - 10.1111/ene.15466

M3 - Conference paper (not formally published)

ER -

Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Results by Age, Disease Duration, and Baseline "Off" Time

Access to Document

Other files and links

Cite this